Morgan Stanley’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.1K | Buy |
34,095
+6,029
| +21% | +$6.39K | ﹤0.01% | 6468 |
|
|
2025
Q1 | $30.6K | Sell |
28,066
-13,697
| -33% | -$14.9K | ﹤0.01% | 6432 |
|
|
2024
Q4 | $63.1K | Sell |
41,763
-17,658
| -30% | -$26.7K | ﹤0.01% | 6218 |
|
|
2024
Q3 | $88.5K | Sell |
59,421
-59,816
| -50% | -$89.1K | ﹤0.01% | 6049 |
|
|
2024
Q2 | $193K | Sell |
119,237
-302,591
| -72% | -$490K | ﹤0.01% | 5696 |
|
|
2024
Q1 | $717K | Sell |
421,828
-376,528
| -47% | -$640K | ﹤0.01% | 5140 |
|
|
2023
Q4 | $2.47M | Buy |
798,356
+563,037
| +239% | +$1.75M | ﹤0.01% | 4807 |
|
|
2023
Q3 | $1.44M | Sell |
235,319
-120,627
| -34% | -$741K | ﹤0.01% | 4587 |
|
|
2023
Q2 | $2.23M | Sell |
355,946
-274,313
| -44% | -$1.72M | ﹤0.01% | 4362 |
|
|
2023
Q1 | $3.01M | Sell |
630,259
-509,003
| -45% | -$2.43M | ﹤0.01% | 4188 |
|
|
2022
Q4 | $9.91M | Sell |
1,139,262
-174,641
| -13% | -$1.52M | ﹤0.01% | 3102 |
|
|
2022
Q3 | $15.6M | Sell |
1,313,903
-1,772,060
| -57% | -$21.1M | ﹤0.01% | 2469 |
|
|
2022
Q2 | $44M | Sell |
3,085,963
-1,303,107
| -30% | -$18.6M | 0.01% | 1476 |
|
|
2022
Q1 | $91.4M | Buy |
4,389,070
+4,063,103
| +1,246% | +$84.6M | 0.01% | 919 |
|
|
2021
Q4 | $7.53M | Buy |
325,967
+288,078
| +760% | +$6.65M | ﹤0.01% | 3277 |
|
|
2021
Q3 | $1.13M | Sell |
37,889
-30,439
| -45% | -$906K | ﹤0.01% | 4975 |
|
|
2021
Q2 | $2.34M | Buy |
68,328
+58,105
| +568% | +$1.99M | ﹤0.01% | 4513 |
|
|
2021
Q1 | $337K | Sell |
10,223
-21,573
| -68% | -$711K | ﹤0.01% | 5369 |
|
|
2020
Q4 | $1.96M | Buy |
31,796
+24,896
| +361% | +$1.53M | ﹤0.01% | 4175 |
|
|
2020
Q3 | $245K | Buy |
+6,900
| New | +$245K | ﹤0.01% | 5004 |
|